The American Association of Neurology is hosting its annual meeting this week in Washington, DC. Through the end of this week, major biotechnology …
It’s been an eventful week on the pipeline front with companies like Biogen Inc (NASDAQ:BIIB), Prothena Corporation PLC (NASDAQ:PRTA) and Vertex Pharmaceuticals Incorporated …
Biogen Idec Inc (NASDAQ: BIIB) presented test results for BIIB037, a drug intended to treat Alzheimer’s disease, on March 20. The medical community …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
J.P.
Biogen Idec Inc (NASDAQ:BIIB) shares were on the rise Friday after the company announced data from a pre-specified interim analysis of PRIME, the Phase 1b …
Even after adding $30 billion in market value over the last four months, shares of Biogen Idec Inc (NASDAQ:BIIB) moved higher on Friday morning with the …
By Sarah Roden It’s been a busy week in the pharmaceutical industry with new data emerging on trial drugs and M&A between drug …
2014 was an eventful year on Wall Street with many ups and downs. Now that 2015 is here, many investors have been wondering …
Volatility reigned in January on elevated volume as stock investors shifted their focus from global events to U.S.
